us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) GuruFocus
📢 Published on 📅 30 January 2026 🕒 12:04 am
Gilead Sciences CEO O’Day sells $1.39 million in stock - Investing.com
Gilead Sciences CEO O’Day sells $1.39 million in stock Investing.com
📢 Published on 📅 29 January 2026 🕒 11:29 pm
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 10,000 Shares of Stock - MarketBeat
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 10,000 Shares of Stock MarketBeat
📢 Published on 📅 29 January 2026 🕒 11:18 pm
RPG: ‘Wrath & Glory Adventures In Gilead’ – Fight Rampaging Orks, Chaos, And More - Bell of Lost Souls
RPG: ‘Wrath & Glory Adventures In Gilead’ – Fight Rampaging Orks, Chaos, And More Bell of Lost Souls
📢 Published on 📅 29 January 2026 🕒 8:45 pm
Gilead to hold town meeting March 28 at Town Hall - sunjournal.com
Gilead to hold town meeting March 28 at Town Hall sunjournal.com
📢 Published on 📅 29 January 2026 🕒 7:15 pm
Championing HIV Support in Italy Through Community-Based Checkpoints - Gilead Sciences
Championing HIV Support in Italy Through Community-Based Checkpoints Gilead Sciences
📢 Published on 📅 29 January 2026 🕒 4:14 pm
March 13th Options Now Available For Gilead Sciences (GILD) - Nasdaq
March 13th Options Now Available For Gilead Sciences (GILD) Nasdaq
📢 Published on 📅 29 January 2026 🕒 4:12 pm
Truist Securities reiterates Buy rating on Gilead Sciences stock at $145 target - Investing.com
Truist Securities reiterates Buy rating on Gilead Sciences stock at $145 target Investing.com
📢 Published on 📅 29 January 2026 🕒 3:50 pm
Wolfe Research Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat
Wolfe Research Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price MarketBeat
📢 Published on 📅 29 January 2026 🕒 3:23 pm
Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD) - StreetInsider
Truist Securities Reiterates Buy Rating on Gilead Sciences (GILD) StreetInsider
📢 Published on 📅 29 January 2026 🕒 2:48 pm
Gilead continues California cuts with 34 laid off, and more pharma payoffs - PharmaLive
Gilead continues California cuts with 34 laid off, and more pharma payoffs PharmaLive
📢 Published on 📅 29 January 2026 🕒 2:01 pm
J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $150 - 富途牛牛
J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $150 富途牛牛
📢 Published on 📅 29 January 2026 🕒 1:46 pm
Ruffer LLP Raises Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Ruffer LLP Raises Stake in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 29 January 2026 🕒 1:37 pm
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink? - Barchart.com
Are Wall Street Analysts Predicting Gilead Sciences Stock Will Climb or Sink? Barchart.com
📢 Published on 📅 29 January 2026 🕒 1:23 pm
New York State Common Retirement Fund Sells 89,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
New York State Common Retirement Fund Sells 89,400 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 29 January 2026 🕒 12:38 pm
Mirae Asset Global Investments Co. Ltd. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 29 January 2026 🕒 12:16 pm
Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position - MarketBeat
Gilead Sciences, Inc. $GILD is AustralianSuper Pty Ltd's 9th Largest Position MarketBeat
📢 Published on 📅 29 January 2026 🕒 8:31 am
Gilead’s Trodelvy Win In TNBC Highlights Evolving Oncology Growth Story - Yahoo Finance
Gilead’s Trodelvy Win In TNBC Highlights Evolving Oncology Growth Story Yahoo Finance
📢 Published on 📅 29 January 2026 🕒 3:18 am
Gilead Oncology Momentum Builds As Trodelvy Data Meet Strong Share Gains - simplywall.st
Gilead Oncology Momentum Builds As Trodelvy Data Meet Strong Share Gains simplywall.st
📢 Published on 📅 29 January 2026 🕒 1:51 am
Gilead’s Trodelvy added to NCCN guidelines - The Pharma Letter
Gilead’s Trodelvy added to NCCN guidelines The Pharma Letter
📢 Published on 📅 28 January 2026 🕒 4:44 pm
Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026 - BioSpace
📢 Published on 📅 28 January 2026 🕒 2:27 pm
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
📢 Published on 📅 28 January 2026 🕒 2:00 pm
Gilead price target raised to $145 from $140 at Truist - Yahoo Finance
Gilead price target raised to $145 from $140 at Truist Yahoo Finance
📢 Published on 📅 28 January 2026 🕒 1:20 pm
Federated Hermes Inc. Sells 324,814 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Federated Hermes Inc. Sells 324,814 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 28 January 2026 🕒 11:30 am
Robert Watson Obituary (2026) - Mount Gilead, OH - The Morrow County Sentinel - Legacy | Obituary
Robert Watson Obituary (2026) - Mount Gilead, OH - The Morrow County Sentinel Legacy | Obituary
📢 Published on 📅 28 January 2026 🕒 4:38 am
Trump administration rolls out 15 more high-profile drugs for IRA price negotiations - Fierce Pharma
Trump administration rolls out 15 more high-profile drugs for IRA price negotiations Fierce Pharma
📢 Published on 📅 27 January 2026 🕒 10:44 pm
Gilead Sciences (GILD) Is Up 11.0% After Trodelvy Combo Outperforms Keytruda Chemo In Phase 3 Trial - Has The Bull Case Changed? - Yahoo Finance
📢 Published on 📅 27 January 2026 🕒 10:07 pm
Demystifying Gilead Sciences: Insights From 17 Analyst Reviews - Benzinga
Demystifying Gilead Sciences: Insights From 17 Analyst Reviews Benzinga
📢 Published on 📅 27 January 2026 🕒 9:01 pm
Gilead’s Trodelvy Data Sparks Questions On Valuation And Oncology Growth - simplywall.st
Gilead’s Trodelvy Data Sparks Questions On Valuation And Oncology Growth simplywall.st
📢 Published on 📅 27 January 2026 🕒 7:32 pm
Truist Securities Raises Price Target for Gilead Sciences (GILD) to $145 | GILD Stock News - GuruFocus
Truist Securities Raises Price Target for Gilead Sciences (GILD) to $145 | GILD Stock News GuruFocus
📢 Published on 📅 27 January 2026 🕒 4:34 pm
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $145.00 - MarketBeat
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $145.00 MarketBeat
📢 Published on 📅 27 January 2026 🕒 4:19 pm
‘The Testaments’ Returns to Gilead as Hulu Sets Premiere for ‘Handmaid’s Tale’ Sequel - EURweb
‘The Testaments’ Returns to Gilead as Hulu Sets Premiere for ‘Handmaid’s Tale’ Sequel EURweb
📢 Published on 📅 27 January 2026 🕒 4:16 pm
Citigroup Raises Price Target for Gilead Sciences (GILD) to $156 - GuruFocus
Citigroup Raises Price Target for Gilead Sciences (GILD) to $156 GuruFocus
📢 Published on 📅 27 January 2026 🕒 3:38 pm
Citigroup Increases Gilead Sciences (NASDAQ:GILD) Price Target to $156.00 - MarketBeat
Citigroup Increases Gilead Sciences (NASDAQ:GILD) Price Target to $156.00 MarketBeat
📢 Published on 📅 27 January 2026 🕒 3:29 pm
Truist Securities raises Gilead Sciences stock price target to $145 - Investing.com
Truist Securities raises Gilead Sciences stock price target to $145 Investing.com
📢 Published on 📅 27 January 2026 🕒 3:15 pm
Kornitzer Capital Management Inc. KS Reduces Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Kornitzer Capital Management Inc. KS Reduces Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 27 January 2026 🕒 1:04 pm
J. Safra Sarasin Holding AG Boosts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
J. Safra Sarasin Holding AG Boosts Stock Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 27 January 2026 🕒 10:33 am
Chilton Capital Management LLC Has $49 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Chilton Capital Management LLC Has $49 Million Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 27 January 2026 🕒 10:07 am
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High Following Analyst Upgrade MarketBeat
📢 Published on 📅 27 January 2026 🕒 6:12 am
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 115,640 Shares - MarketBeat
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 115,640 Shares MarketBeat
📢 Published on 📅 27 January 2026 🕒 1:26 am
Gilead Sciences CEO O’Day sells $15.6 million in stock By Investing.com - Investing.com Nigeria
Gilead Sciences CEO O’Day sells $15.6 million in stock By Investing.com Investing.com Nigeria
📢 Published on 📅 27 January 2026 🕒 12:58 am
Praise Be: ‘The Testaments’ Finally Has a Premiere Date and Gilead is Getting a Makeover - The TV Cave
Praise Be: ‘The Testaments’ Finally Has a Premiere Date and Gilead is Getting a Makeover The TV Cave
📢 Published on 📅 26 January 2026 🕒 7:19 pm
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00 - MarketBeat
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00 MarketBeat
📢 Published on 📅 26 January 2026 🕒 6:42 pm
Hulu sets date for return to Gilead - AV Club
Hulu sets date for return to Gilead AV Club
📢 Published on 📅 26 January 2026 🕒 6:10 pm
‘Handmaid’s Tale’ Sequel Series ‘The Testaments’ Sets Premiere Date - hollywoodreporter.com
‘Handmaid’s Tale’ Sequel Series ‘The Testaments’ Sets Premiere Date hollywoodreporter.com
📢 Published on 📅 26 January 2026 🕒 4:16 pm
Gilead Sciences stock price target raised to $150 by BMO Capital - Investing.com
Gilead Sciences stock price target raised to $150 by BMO Capital Investing.com
📢 Published on 📅 26 January 2026 🕒 3:58 pm
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 at BMO Capital Markets - MarketBeat
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 at BMO Capital Markets MarketBeat
📢 Published on 📅 26 January 2026 🕒 2:35 pm
Gilead’s Trodelvy plus Keytruda shows positive results in metastatic breast cancer - PMLiVE
Gilead’s Trodelvy plus Keytruda shows positive results in metastatic breast cancer PMLiVE
📢 Published on 📅 26 January 2026 🕒 12:49 pm
Mutual of America Capital Management LLC Sells 8,657 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Mutual of America Capital Management LLC Sells 8,657 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 26 January 2026 🕒 12:15 pm
Commerzbank Aktiengesellschaft FI Purchases Shares of 12,471 Gilead Sciences, Inc. $GILD - MarketBeat
Commerzbank Aktiengesellschaft FI Purchases Shares of 12,471 Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 26 January 2026 🕒 9:38 am
Gilead Sciences, Inc. $GILD Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by AEGON ASSET MANAGEMENT UK Plc MarketBeat
📢 Published on 📅 26 January 2026 🕒 8:05 am
Gilead Sciences, Inc. $GILD is Sector Gamma AS's 9th Largest Position - MarketBeat
Gilead Sciences, Inc. $GILD is Sector Gamma AS's 9th Largest Position MarketBeat
📢 Published on 📅 25 January 2026 🕒 12:34 pm
First Citizens Bank & Trust Co. Purchases 61,959 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
First Citizens Bank & Trust Co. Purchases 61,959 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 25 January 2026 🕒 10:01 am
AMF Tjanstepension AB Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
AMF Tjanstepension AB Reduces Holdings in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 25 January 2026 🕒 8:22 am
Mn Services Vermogensbeheer B.V. Acquires 8,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Mn Services Vermogensbeheer B.V. Acquires 8,500 Shares of Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 24 January 2026 🕒 2:01 pm
Gilead Sciences, Inc. $GILD Shares Sold by Resona Asset Management Co. Ltd. - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Resona Asset Management Co. Ltd. MarketBeat
📢 Published on 📅 24 January 2026 🕒 1:44 pm
Gilead Sciences, Inc. $GILD Stake Increased by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Gilead Sciences, Inc. $GILD Stake Increased by Mitsubishi UFJ Trust & Banking Corp MarketBeat
📢 Published on 📅 24 January 2026 🕒 1:23 pm
UniSuper Management Pty Ltd Has $62.38 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
UniSuper Management Pty Ltd Has $62.38 Million Stake in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 24 January 2026 🕒 1:23 pm
Teacher Retirement System of Texas Has $36.91 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Teacher Retirement System of Texas Has $36.91 Million Stock Position in Gilead Sciences, Inc. $GILD MarketBeat
📢 Published on 📅 24 January 2026 🕒 12:04 pm
Gilead Sciences, Inc. $GILD Shares Acquired by Envestnet Portfolio Solutions Inc. - MarketBeat
Gilead Sciences, Inc. $GILD Shares Acquired by Envestnet Portfolio Solutions Inc. MarketBeat
📢 Published on 📅 24 January 2026 🕒 12:04 pm
Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy - MarketBeat
Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy MarketBeat
📢 Published on 📅 24 January 2026 🕒 5:48 am
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences Inc. stock outperforms competitors on strong trading day MarketWatch
📢 Published on 📅 23 January 2026 🕒 9:30 pm
How Investors May Respond To Gilead Sciences (GILD) Trodelvy Keytruda Breast Cancer Data In NEJM - simplywall.st
How Investors May Respond To Gilead Sciences (GILD) Trodelvy Keytruda Breast Cancer Data In NEJM simplywall.st
📢 Published on 📅 23 January 2026 🕒 1:30 pm
Why Gilead Sciences (GILD) Outpaced the Stock Market Today - Yahoo Finance
Why Gilead Sciences (GILD) Outpaced the Stock Market Today Yahoo Finance
📢 Published on 📅 22 January 2026 🕒 11:00 pm
Gilead Sciences publishes Trodelvy-Keytruda data in NEJM - The Pharma Letter
Gilead Sciences publishes Trodelvy-Keytruda data in NEJM The Pharma Letter
📢 Published on 📅 22 January 2026 🕒 12:14 pm
JPM26, Day 3: Gilead's CMO talks virus strategy - Fierce Biotech
JPM26, Day 3: Gilead's CMO talks virus strategy Fierce Biotech
📢 Published on 📅 14 January 2026 🕒 8:00 am
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength' - Fierce Biotech
JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength' Fierce Biotech
📢 Published on 📅 14 January 2026 🕒 8:00 am
JPM26: HIV pipeline dosing optionality gives Gilead advantage - Clinical Trials Arena
JPM26: HIV pipeline dosing optionality gives Gilead advantage Clinical Trials Arena
📢 Published on 📅 13 January 2026 🕒 12:03 pm
On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash - statnews.com
On Day 2 of JPM, Gilead lays outs it next test, a VC looks to raise funds, and one firm has FDA whiplash statnews.com
📢 Published on 📅 13 January 2026 🕒 8:00 am
Inside Gilead’s 2030 Strategy to Advance 10 Transformative Therapies - Endpoints News
Inside Gilead’s 2030 Strategy to Advance 10 Transformative Therapies Endpoints News
📢 Published on 📅 12 January 2026 🕒 11:00 am
UBS and Citi Go Bullish on Gilead Sciences (GILD) - Yahoo Finance
UBS and Citi Go Bullish on Gilead Sciences (GILD) Yahoo Finance
📢 Published on 📅 12 January 2026 🕒 8:00 am
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says - Reuters
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says Reuters
📢 Published on 📅 12 January 2026 🕒 8:00 am
Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing Yahoo Finance
📢 Published on 📅 12 January 2026 🕒 8:00 am
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration - Yahoo Finance
The Bull Case For Gilead Sciences (GILD) Could Change Following New OncoNano Drug-Delivery Collaboration Yahoo Finance
📢 Published on 📅 11 January 2026 🕒 8:00 am
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication - Fierce Biotech
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication Fierce Biotech
📢 Published on 📅 7 January 2026 🕒 8:00 am
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum - Yahoo Finance
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum Yahoo Finance
📢 Published on 📅 7 January 2026 🕒 8:00 am
Gilead garners lipid package for cancer asset in $300M pact - Fierce Biotech
Gilead garners lipid package for cancer asset in $300M pact Fierce Biotech
📢 Published on 📅 6 January 2026 🕒 8:00 am
AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals - Fierce Biotech
AbbVie, Gilead gift themselves clinical-stage cancer drugs via licensing deals Fierce Biotech
📢 Published on 📅 2 January 2026 🕒 8:00 am
Gilead Sciences to acquire Repare’s RP-3467 - Pharmaceutical Technology
Gilead Sciences to acquire Repare’s RP-3467 Pharmaceutical Technology
📢 Published on 📅 26 December 2025 🕒 8:00 am
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact - Fierce Biotech
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact Fierce Biotech
📢 Published on 📅 22 December 2025 🕒 8:00 am
Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings - Fierce Pharma
Gilead's single-tablet HIV combo of bictegravir, lenacapavir passes another late-stage test on way to filings Fierce Pharma
📢 Published on 📅 16 December 2025 🕒 8:00 am
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV treatment meets primary endpoint in Phase 3 ARTISTRY-2 trial - European AIDS Treatment Group
Gilead’s investigational single-tablet regimen of bictegravir and lenacapavir for HIV treatment meets primary endpoint in Phase 3 ARTISTRY-2 trial European AIDS Treatment Group
📢 Published on 📅 15 December 2025 🕒 10:57 pm
Arcus cancels work on Gilead-partnered cancer combo after trial setback - BioPharma Dive
Arcus cancels work on Gilead-partnered cancer combo after trial setback BioPharma Dive
📢 Published on 📅 12 December 2025 🕒 8:00 am
Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates - Yahoo Finance
Why The Narrative Around Gilead Sciences Is Shifting After HIV And Oncology Updates Yahoo Finance
📢 Published on 📅 7 December 2025 🕒 8:00 am
Gilead scoops up a preclinical cancer program - BioPharma Dive
Gilead scoops up a preclinical cancer program BioPharma Dive
📢 Published on 📅 25 November 2025 🕒 8:00 am
Gilead hatches $400M biobucks deal for Swedish biotech's TREX1 cancer program - Fierce Biotech
Gilead hatches $400M biobucks deal for Swedish biotech's TREX1 cancer program Fierce Biotech
📢 Published on 📅 24 November 2025 🕒 8:00 am
Gilead and GLAAD Partner for a Powerful Virtual Dialogue During Transgender Awareness Week - GLAAD
Gilead and GLAAD Partner for a Powerful Virtual Dialogue During Transgender Awareness Week GLAAD
📢 Published on 📅 19 November 2025 🕒 8:00 am
Gilead Foundation Launches STEM Careers Partnership with Boys & Girls Clubs of America - Boys & Girls Clubs of America
Gilead Foundation Launches STEM Careers Partnership with Boys & Girls Clubs of America Boys & Girls Clubs of America
📢 Published on 📅 16 October 2025 🕒 7:00 am
Gilead presents new HIV research data at EACS 2025 – driving scientific innovation in treatment and prevention - European AIDS Treatment Group
Gilead presents new HIV research data at EACS 2025 – driving scientific innovation in treatment and prevention European AIDS Treatment Group
📢 Published on 📅 15 October 2025 🕒 11:00 pm
Gilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer win - Clinical Trials Arena
Gilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer win Clinical Trials Arena
📢 Published on 📅 14 October 2025 🕒 7:00 am
Case overview, Gilead Sciences v Meritain Health, et al - Partnership for Safe Medicines
Case overview, Gilead Sciences v Meritain Health, et al Partnership for Safe Medicines
📢 Published on 📅 4 October 2025 🕒 8:51 am
Gilead Sciences (GILD): Company Profile, Stock Price, News, Rankings - Fortune
Gilead Sciences (GILD): Company Profile, Stock Price, News, Rankings Fortune
📢 Published on 📅 24 September 2025 🕒 7:00 am
Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - gov.ca.gov
📢 Published on 📅 15 September 2025 🕒 7:00 am
Gilead Sciences Commits to Veeva Vault CRM - Veeva
Gilead Sciences Commits to Veeva Vault CRM Veeva
📢 Published on 📅 10 September 2025 🕒 7:00 am
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest - AIDS Healthcare Foundation
Gilead Price Hikes Screw ADAP Programs, HIV Patients--AHF Protest AIDS Healthcare Foundation
📢 Published on 📅 9 September 2025 🕒 7:00 am
What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025 - Yahoo Finance
What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025 Yahoo Finance
📢 Published on 📅 9 September 2025 🕒 7:00 am
Department of State, Gilead Sciences, and The Global Fund Announcement of Lifesaving and Innovative PEPFAR Initiative - U.S. Department of State (.gov)
Department of State, Gilead Sciences, and The Global Fund Announcement of Lifesaving and Innovative PEPFAR Initiative U.S. Department of State (.gov)
📢 Published on 📅 4 September 2025 🕒 7:00 am
Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius - BioPharma Dive
Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius BioPharma Dive
📢 Published on 📅 21 August 2025 🕒 7:00 am
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme - oag.dc.gov
Attorney General Schwalb Recovers Over $300,000 from Gilead Sciences for Illegal Kickback Scheme oag.dc.gov
📢 Published on 📅 15 July 2025 🕒 7:00 am
Gilead: 2025 TIME100 Most Influential Companies - Time Magazine
Gilead: 2025 TIME100 Most Influential Companies Time Magazine
📢 Published on 📅 26 June 2025 🕒 7:00 am
